Detection in serum of antilymphocyte-globulin administered in form of eye-drops

Rosette inhibition tests indicated that similarly as in previous animal experiments, anti-human lymphocyte horse globulin (AHLG) administered in the form of eye-drops entered the systemic blood circulation in man. In the eye into which the AHLG is administered, it is expected to exert a local immunosuppressive effect.